Krensavage Asset Management, LLC Portfolio Holdings
Krensavage Asset Management, LLC
- $235 Million
- Q3 2025
Krensavage Asset Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $235 Million distributed in 17 stocks.
Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $40.9M, Enanta Pharmaceuticals Inc with a value of $25.3M, Jazz Pharmaceuticals PLC with a value of $22.1M, Biomarin Pharmaceutical Inc with a value of $22M, and Exelixis, Inc. with a value of $21.4M.
Examining the 13F form we can see an increase of $45.8M in the current position value, from $189M to 235M.
Krensavage Asset Management, LLC is based out at New York, NY
Below you can find more details about Krensavage Asset Management, LLC portfolio as well as his latest detailed transactions.